©2024 cardiocycle. All Rights Reserved.
  • Our Stories

    CardioCycle R&D Ltd. Is a medical device company based in Galway, Ireland and Suzhou ,China connecting to the world. We aim to bring innovative concepts to reality.

Our Profile

CardioCycle founded in 2020, is a high-end enterprise engaged in the research and development, production, and sales of medical devices. It was established by core engineers in the medical device industry, clinical experts, and capital investors.

We focus on providing one-stop solutions for interventional therapy. Production and R&D centers are set up in Suzhou Biobay and Galway GMIT, Ireland. We are committed to being a deep research and development and manufacturing interventional medical solutions provider, serving patients and contributing to the world.

Corporate Spirit: Innovate for development and strive for perfection.

Corporate Values: People-oriented, Long-term Learing, Innovation.

Corporate Vision: To provide healthcare for the general public and expand healthcare through innovation

Corporate Mission: Benefit the public with medical care and expand medical services through innovation.


China+Ireland
Ireland is a global hub for the R&D and production of medical devices. It is the first company in China to establish an R&D & production center in Ireland.
10 Year+
The core team (R&D, production, quality, registration) consists of senior personnel from the interventional industry, with top-tier implementation capabilities.
Diversified blue ocean product line
Product line 11+
Exploring blue ocean products
Commercialization
5+ Class III products approved Entering sales in 202 4, entering the company's selfsustaining phase

Our Stories

In 2024

In May, Phase V of Biobay, more than 3,000 square meters for production and office use, was officially launched.

In 2023

In July, the balloon occlusion microcatheter acquired the first Class III medical device registration certificate.

In December, we obtained 3 pieces of Class III medical device registration certificates and began to build a one-stop precision interventional treatment product line.

In 2022

In March, Phase I of Biobay, with over 1,000 square meters of production and office area, was officially opened.

In April, the company was recognized as a small and medium-sized tech enterprise.

In July, it was identified as a private tech enterprise in Jiangsu Province.

In 2021

We was founded on July 1, 2021.

Our Honors

  • Private technology enterprises in jiangsu province
  • 2022 Gusu innovation and entrepreneurship leading talent enterprise
  • 2023 Park science and technology leading talent enterprise
环心医疗官方公众号